Therapy of candidosis vulvovaginitis at pregnancy

Abstract

Clinical effectiveness gyno-pevaryl (GP) is investigated at treatment acute (30 women) and chronic (38 patients) candidosis vulvovaginitis in the period of pregnancy. In an end of course of treatment GP clinical and laboratory the confirmed recovery is marked in the first group at 80.0 % patients, in the second and the third - at 76.3 % patients. Gynopevaryl is an effective preparation for local treatment acute and chronic candidosis vulvovaginitis.